In metastatic tumor cells, ID1 and ID3 facilitate the mesenchymal-to-epithelial conversion required for macro-metastatic disease progression, likely through antagonism of the bHLH protein Twist47. This evidence concerns the gene ID3 and metastatic neoplasm.